Learn more about MRA’s well-established program for microbiological control and validation for Biologics Therapies, including:
- Chimeric Antigen Receptor Cells (CAR-T)
- Tumor Specific Peptide Vaccines
- Tissue Regeneration
- Bone Marrow Replacement
Our services include microbiological characterization and method development to determine validity for final product sterility and endotoxin levels. Furthermore, MRA can assist in evaluating in-process bioburden loads and media feed asepsis. MRA offers ongoing environmental monitoring and process validations to insure that quality standards are met. Prompt reporting, with same day testing, provides clients with results needed to support decision making and planning.
MRA is an FDA registered lab that strictly adheres to good lab practices.
We invite you to contact us for assistance on product performance and quality verification.